Pertzye 4000 IU Digestive Care

Pharmaceutical Form
Delayed – Release capsules
Bicarbonate buffered enteric coated microspheres

Indications
PERTZYE® (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.

Article Number
765680

Pertzye

For more information

Summary of product characteristics

Read more:
Pertzye

Pertzye 8000 IU Digestive Care

Pharmaceutical Form
Delayed – Release capsules
Bicarbonate buffered enteric coated microspheres

Indications
PERTZYE® (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.

Article Number
765681

Pertzye

For more information

Summary of product characteristics

Read more:
Pertzye

Pertzye 16000 IU Digestive Care

Pharmaceutical Form
Delayed – Release capsules
Bicarbonate buffered enteric coated microspheres

Indications
PERTZYE® (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.

Article Number
765682

 

Pertzye

For more information

Summary of product characteristics

Read more:
Pertzye

Pertzye 24000 IU Digestive Care

Pharmaceutical Form
Delayed – Release capsules
Bicarbonate buffered enteric coated microspheres

Indications
PERTZYE® (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions.

Article Number
765683

 

Pertzye

For more information

Summary of product characteristics

Read more:
Pertzye

EnglishSwedish